XPF-001 clinical trials
Also written XPF-001.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses XPF-001 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- XPF-001
- 3
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses XPF-001 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth ExtractionCompletedPhase 2Xenon Pharmaceuticals Inc.NCT00954356Written as XPF-001How we know
- Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)CompletedPhase 1/2Xenon Pharmaceuticals Inc.NCT01090622Written as XPF-001How we know
- Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy VolunteersCompletedPhase 1Xenon Pharmaceuticals Inc.NCT00813670Written as XPF-001How we know